TWIN FOCUS CAPITAL PARTNERS, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 188 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWIN FOCUS CAPITAL PARTNERS, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$222,000
+7.8%
4,5160.0%0.11%
+9.6%
Q4 2017$206,000
-4.2%
4,5160.0%0.10%
-11.9%
Q2 2017$215,000
+4.4%
4,5160.0%0.12%
-4.8%
Q1 2017$206,000
-6.4%
4,516
-33.7%
0.12%
-13.3%
Q4 2016$220,000
-5.6%
6,8160.0%0.14%
-11.2%
Q3 2016$233,000
+1.3%
6,8160.0%0.16%
-11.5%
Q2 2016$230,000
-36.3%
6,8160.0%0.18%
-46.8%
Q1 2016$361,000
-31.0%
6,8160.0%0.34%
-35.0%
Q4 2015$523,000
+86.8%
6,8160.0%0.53%
+47.3%
Q3 2015$280,000
-41.9%
6,8160.0%0.36%
-34.1%
Q2 2015$482,000
-20.5%
6,8160.0%0.54%
+13.9%
Q1 2015$606,000
+0.3%
6,8160.0%0.48%
-32.3%
Q4 2014$604,000
-8.6%
6,8160.0%0.70%
+8.3%
Q3 2014$661,000
-29.6%
6,816
-33.3%
0.65%
-38.5%
Q2 2014$939,000
+31.1%
10,2230.0%1.06%
+24.1%
Q1 2014$716,000
+24.7%
10,223
+2.4%
0.85%
+50.2%
Q4 2013$574,0009,9810.57%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders